TGA Warning On The Risks Of Importing Unapproved Peptide Products

Recall Summary The Australian Therapeutic Goods Administration is warning consumers against importing unapproved peptide products that are being sold online. These products have not been evaluated or approved for safety and effectiveness in Australia. The warning applies to consumers across Australia.

Reason
We are warning consumers about the risks of importing and using unapproved peptide products that are promoted online.
Classification
Class II
Category
drug recall
Country
Australia
Agency
Therapeutic Goods Administration
Recall date
2026-05-07
Status
Ongoing
Distribution
Australia-wide

Official recall notice from Therapeutic Goods Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/7dd73387-a807-488c-a65e-fca7357dbf75